亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

A Diagnostic Test for Monitoring of Lupus Nephritis

技术应用
Discrimination between patients with activeLN and active non-LNMonitoring disease activity and response totherapyAccurately stratifying patients with regardsto extent and nature of renal injury without in vivo interventionInforming long-term prognosis
详细技术说明
Validatedurine test for the diagnosis, monitoring and prognosis of Lupus Nephritis
*Abstract

Lupus nephritis (LN)is a major predictor of poor prognosis of the patients with systemic lupuserythematosus (SLE). The incident rate for SLE varies from 7.4 to 159.4 casesper 100,000 people. Since renal involvement is a major complication of thedisease current diagnostic of LN includes renal biopsy to confirm disease andto establish histopathological classification of the underlying renal lesion.Identification of histopathological differences is critical for establishingappropriate therapeutic interventions and for prognostic outcomes for LN. Nosuitable biomarkers that predict early response to therapy or forecast renalflares have been identified.

The urinarytest was developed (60 active LN patients, 25 active non-LN SLE patients and 24healthy controls) and validated (for numbers see figure legend) by researchersfrom the University Health Network in collaboration with the researcher fromthe Ontario Institute for Cancer Research. Eight (8) urinary proteins aredifferentially expressed in patients with proliferative and non-proliferativeor chronic lesions on renal biopsy.

Thevalidation study for some of urinary proteins presented in the figure below.

Thescattered plots demonstrate the normalized concentration of adiponectin, plasminogenactivator inhibitor-1 (PAI-1), interleukin 15 (IL-15), platelet factor 4 (PF4)and metalloproteinase-1 (TIMP-1). The study included SLE patients with active non-LN(ANLN, n=16, closed circles), active LN (ALN, n=33, closed triangles) and inremission (n=30, open triangles).

*Principal Investigation

Dr. Joan Wither, University HealthNetwork (lead researcher)

*Publications
Landolt-Marticorena C, Prokopec SD, Morrison S, Noamani B, Bonilla D, and Wither J. A discrete cluster of urinary biomarkers discriminates between active Systemic Lupus Erythematosus patients with and without glomerulonephritis. Arthritis Research and Therapy (2016) 18:2118
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备